Tiziana Life Sciences Ltd (TLSA) has a current Price-to-Book (P/B) ratio of 20.67. Compared to its 3-year average P/B ratio of 24.28, the current P/B ratio is approximately -14.89% higher. Relative to its 5-year average P/B ratio of 17.27, the current P/B ratio is about 19.67% higher. Tiziana Life Sciences Ltd (TLSA) has a Forward Free Cash Flow (FCF) yield of approximately -4.61%. Compared to its 3-year average FCF yield of -15.42%, the current FCF yield is approximately -70.12% lower. Relative to its 5-year average FCF yield of -18.99%, the current FCF yield is about -75.73% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for TLSA competitors is 2.04, providing a benchmark for relative valuation. Tiziana Life Sciences Ltd Corp (TLSA.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of TLSA increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of TLSA in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is TLSA currently overvalued or undervalued?

What is Tiziana Life Sciences Ltd (TLSA) fair value?

TLSA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Tiziana Life Sciences Ltd (TLSA) is between to according to relative valuation method.

How does TLSA's valuation metrics compare to the industry average?

The average P/S ratio for TLSA's competitors is 2.04, providing a benchmark for relative valuation. Tiziana Life Sciences Ltd Corp (TLSA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Tiziana Life Sciences Ltd (TLSA) as of Mar 04 2026?

As of Mar 04 2026, Tiziana Life Sciences Ltd (TLSA) has a P/B ratio of 20.67. This indicates that the market values TLSA at 20.67 times its book value.

What is the current FCF Yield for Tiziana Life Sciences Ltd (TLSA) as of Mar 04 2026?

As of Mar 04 2026, Tiziana Life Sciences Ltd (TLSA) has a FCF Yield of -4.61%. This means that for every dollar of Tiziana Life Sciences Ltd's market capitalization, the company generates -4.61 cents in free cash flow.

What is the current Forward P/E ratio for Tiziana Life Sciences Ltd (TLSA) as of Mar 04 2026?

As of Mar 04 2026, Tiziana Life Sciences Ltd (TLSA) has a Forward P/E ratio of -8.46. This means the market is willing to pay $-8.46 for every dollar of Tiziana Life Sciences Ltd's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Tiziana Life Sciences Ltd (TLSA) as of Mar 04 2026?

As of Mar 04 2026, Tiziana Life Sciences Ltd (TLSA) has a Forward P/S ratio of 0.00. This means the market is valuing TLSA at $0.00 for every dollar of expected revenue over the next 12 months.

TLSA Valuation